SEC FORM 13F-HR

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: Oct 31, 2018
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 03-31-2023
Check here if Amendment    Amendment Number:
This Amendment (Check only one.):    is a restatement.
   adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Carlyle Group Inc.
Address: C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON, DC  20004
Form 13F File Number: 028-15025

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Jeffrey W. Ferguson
Title: General Counsel
Phone: 202-729-5626
Signature, Place, and Date of Signing:
/s/ Jeffrey W. Ferguson WashingtonDC 05-05-2023
[Signature] [City, State] [Date]
Explanatory Note 1: AlpInvest Partners B.V. is an indirectly wholly owned investment adviser of The Carlyle Group Inc. However, The Carlyle Group Inc. does not participate in any investment decision-making of AlpInvest Partners B.V. -- Explanatory Note 2: On August 1, 2022, The Carlyle Group Inc. completed its acquisition of the Abingworth group, a life sciences investment firm. As a result of the acquisition, Abingworth LLP has become a relying advisor of Carlyle Investment Management L.L.C. Abingworth Management Inc. is de-registering as an investment adviser with the United States Securities and Exchange Commission.
Report Type (Check only one.):
   13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
   13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
X 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name
028-15646 AlpInvest Partners B.V.
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 3
Form 13F Information Table Entry Total: 31
Form 13F Information Table Value Total: 3,352,222,730
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name
1 028-14285 Abingworth LLP
2 028-12429 Carlyle Investment Management LLC
3 028-15024 CIM Global, L.L.C.

SEC FORM 13-F Information Table

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: Oct 31, 2018
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adicet Bio Inc Com 007002108 12,163,464 2,115,385 SH   DFND 1 0 2,115,385 0
Aeglea Biotherapeutics Inc Com 00773J103 69,024 240,500 SH   DFND 1 0 240,500 0
CubeSmart Com 229663109 10,191,510 220,500 SH   DFND 2 0 220,500 0
Cymabay Therapeutics Inc Com 23257D103 1,143,944 131,036 SH   DFND 1 0 131,036 0
Effector Therapeutics Inc Com 28202V108 1,687,740 4,822,114 SH   DFND 1 0 4,822,114 0
Exicure Inc Com New 30205M200 242,207 281,636 SH   DFND 1 0 281,636 0
GDS Hldgs Ltd Sponsored Ads 36165L108 75,995,171 4,072,624 SH   DFND 2,3 0 4,072,624 0
Getty Images Holdings Inc Cl A Com 374275105 60,585,339 11,902,817 SH   DFND 2 0 11,902,817 0
Hillevax Inc Com 43157M102 30,096,016 1,838,486 SH   DFND 1 0 1,838,486 0
Invitation Homes Inc Com 46187W107 14,912,325 477,500 SH   DFND 2 0 477,500 0
Jasper Therapeutics Inc Com 471871103 15,771,404 8,761,891 SH   DFND 1 0 8,761,891 0
Life Storage Inc Com 53223X107 11,273,740 86,000 SH   DFND 2 0 86,000 0
Meta Data Limited Sponsored Ads 68276W400 329,303 314,400 SH   DFND 2,3 0 314,400 0
MKS Instrs Inc Com 55306N104 292,685,452 3,302,702 SH   DFND 2,3 0 3,302,702 0
MKS Instrs Inc Com 55306N104 459,054,259 5,180,030 SH   DFND 2 0 5,180,030 0
Molecular Templates Inc Com 608550109 75,020 200,000 SH   DFND 1 0 200,000 0
Nucana Plc Sponsored Adr 67022C106 3,200,333 3,333,333 SH   DFND 1 0 3,333,333 0
Paratek Pharmaceuticals Inc Com 699374302 2,623,650 1,041,131 SH   DFND 1 0 1,041,131 0
Phathom Pharmaceuticals Inc Com 71722W107 20,868,604 2,935,106 SH   DFND 1 0 2,935,106 0
Quidelortho Corp Com 219798105 1,110,077,703 12,460,183 SH   DFND 2 0 12,460,183 0
Reneo Pharmaceuticals Inc Com 75974E103 12,236,346 2,073,957 SH   DFND 1 0 2,073,957 0
Seacor Marine Hldgs Inc Com 78413P101 9,999,867 1,314,043 SH   DFND 2 0 1,314,043 0
Sientra Inc Com 82621J204 256,058 167,358 SH   DFND 1 0 167,358 0
Smart Sh Global Ltd Ads 83193E102 5,339,331 4,810,209 SH   DFND 2,3 0 4,810,209 0
Soleno Therapeutics Inc Com 834203309 2,535,178 1,201,506 SH   DFND 1 0 1,201,506 0
Spruce Biosciences Inc Com 85209E109 6,401,305 2,896,518 SH   DFND 1 0 2,896,518 0
Vaxcyte Inc Com 92243G108 72,079,962 1,923,158 SH   DFND 1 0 1,923,158 0
Vera Therapeutics Inc Cl A 92337R101 22,882,586 2,960,231 SH   DFND 1 0 2,960,231 0
Verona Pharma Plc Sponsored Ads 925050106 49,346,600 2,457,500 SH   DFND 1 0 2,457,500 0
Vitru Ltd Com G9440D103 142,169,680 6,246,471 SH   DFND 2,3 0 6,246,471 0
ZoomInfo Technologies Inc Common Stock 98980F104 905,929,609 36,662,469 SH   DFND 2 0 36,662,469 0